Clarus Therapeutics Holdings, Inc.
CRXTDelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817944
Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Clarus Therapeutics Holdings, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 2 | 0 | −2 |
| Shares | 158.5K | 0 | −158.5K (−100.0%) |
| Value | $5.00K | $0 | −$5.00K (−100.0%) |
New holders (0)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (2)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Sabby Management, LLC | 146,900 | $5.00K |
| Wealthcare Advisory Partners LLC | 11,578 | $0 |